Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Leukemia. 2020 Aug 5;35(4):1188–1192. doi: 10.1038/s41375-020-1007-6

Figure 2.

Figure 2.

Kaplan-Meier curves depicting the a disease-free survival and b overall survival of de novo acute myeloid leukemia patients with TP73 mutations (blue) compared with those of patients with TP53 mutations (red) and of patients with wild-type (wt) TP73 and TP53 genes (black).